Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 15TCr 13TCr 12TCr 11TCr 21TCr 14,59900Cr 22TCr 1,44300Cr 56TCr 7,10600Cr 58TCr 56TCr 24,60400Cr P/E Ratio 2026 *
22.2x
P/E Ratio 2027 * 19x
Enterprise Value 17TCr 14TCr 13TCr 12TCr 23TCr 15,71400Cr 23TCr 1,55400Cr 61TCr 7,64800Cr 62TCr 61TCr 26,48300Cr EV / Sales 2026 *
3.29x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.89%
Yield 2027 * 3.08%
1 day+0.03%
1 week-3.17%
Current month+3.01%
1 month+4.54%
3 months-18.46%
6 months-29.71%
Current year-29.62%
1 week 87.07
Extreme 87.0706
92.02
1 month 84.05
Extreme 84.05
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
28/04Other

Head of Human Resources

5,314 0.0003%
24/04Free

Director

2,286 0.0001%
24/04Free

Director

2,286 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-3.17%-35.38%-13.04% 15TCr
-0.16%-1.80%-9.37%-4.84% 10TCr
+0.07%+2.41%-4.53%+57.08% 5.48TCr
+3.00%+0.30%+55.27%+51.53% 5.52TCr
-0.75%-3.25%-16.18%-41.67% 4.03TCr
-1.40%+8.93% - - 3.1TCr
+0.16%+3.44%-9.03%-40.61% 2.91TCr
-0.46%+4.55%+46.20%-7.99% 2.32TCr
-2.85%-3.53%-16.97%-1.50% 2.03TCr
+0.16%-2.26%-14.38%-0.16% 2.02TCr
Average -0.22%+0.69%-0.48%-0.13% 5.31TCr
Weighted average by Cap. +0.04%-0.39%-8.14%+0.79%

Financials

2026 *2027 *
Net sales 5.03TCr 4.34TCr 4TCr 3.75TCr 7.02TCr 4,78000Cr 7.13TCr 47TCr 18TCr 2,32700Cr 19TCr 18TCr 8,05600Cr 5.48TCr 4.73TCr 4.36TCr 4.08TCr 7.65TCr 5,20800Cr 7.77TCr 51TCr 20TCr 2,53500Cr 21TCr 20TCr 8,77700Cr
Net income 701.88Cr 606.21Cr 558.63Cr 522.9Cr 979.95Cr 67TCr 995.13Cr 6.6TCr 2.57TCr 32TCr 2.63TCr 2.58TCr 1,12400Cr 839.23Cr 724.84Cr 667.94Cr 625.23Cr 1.17TCr 80TCr 1.19TCr 7.89TCr 3.08TCr 39TCr 3.15TCr 3.08TCr 1,34400Cr
Net Debt 1.17TCr 1.01TCr 933.32Cr 873.63Cr 1.64TCr 1,11500Cr 1.66TCr 11TCr 4.3TCr 54TCr 4.4TCr 4.31TCr 1,87800Cr 888.3Cr 767.22Cr 707Cr 661.78Cr 1.24TCr 84TCr 1.26TCr 8.35TCr 3.25TCr 41TCr 3.33TCr 3.26TCr 1,42300Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
12/26/12 88.18 $ -1.64% 1,37,59,091
11/26/11 89.65 $ +0.54% 1,50,88,866
10/26/10 89.17 $ -2.28% 1,18,53,108
09/26/09 91.25 $ +0.83% 1,41,09,595
08/26/08 90.50 $ -0.63% 1,33,08,687
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
88.18USD
Average target price
116.54USD
Spread / Average Target
+32.16%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!